CIK 0001133416
- Non-accelerated filer
- Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 043562325
- Phone
- +1 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-28 | LEWIS JOEL President and CEO | Grant or award | +9,358 | $1.87 | $17K | 437.94 |
| 2022-02-15 | LEWIS JOEL President and CEO | Grant or award | +8,454 | $2.07 | $17K | 428,585 |
| 2022-02-02 | 10X Fund, L.P. 10% owner | Sale | −10,000 | $2.10 | $21K | 6,178,940 |
| 2022-01-31 | LEWIS JOEL President and CEO | Grant or award | +112,263 | $1.93 | $217K | 420,131 |
| 2022-01-24 | Uihlein Richard E Director | Grant or award | +17,677 | $1.98 | $35K | 7,936,677 |
| 2022-01-24 | Uihlein Richard E Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | Schwartz Elissa J. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | Shlevin Harold H. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | ELDRED KARY Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | CZIRR JAMES C Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | Rubin Marc Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | OMENN GILBERT S Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | Zordani Richard A. Jr. Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | FREEMAN KEVIN D Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | AMELIO GILBERT F Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-24 | CALLICUTT JACK W Chief Financial Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-01-24 | Boudes Pol F Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-01-24 | LEWIS JOEL President and CEO | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2022-01-21 | Schwartz Elissa J. Director | Purchase | +1,000 | $2.00 | $2K | 1,000 |
| 2022-01-19 | FREEMAN KEVIN D Director | Purchase | +5,000 | $1.96 | $10K | 55,000 |
Page 20 of 21 · 404 trades